Synergy Pharmaceuticals’ TRULANCE(TM) (Plecanatide) Receives U.S. FDA Approval for the Treatment of Adults with Chronic Idiopathic Constipation

NEW YORK--(Healthcare Sales & Marketing Network)--Synergy Pharmaceuticals Inc. (SGYP) announced today that the U.S. Food and Drug Administration (FDA) has approved TRULANCE™ (plecanatide) for the treatment of adults with chronic idiopathic constipation (CI... Biopharmaceuticals, Gastroenterology, FDA Synergy Pharmaceuticals, TRULANCE, plecanatide, chronic idiopathic constipation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news